Haemato AG
XETRA:HAEK
Haemato AG
XETRA:HAEK
Price:
21.4
EUR
-1.83%
Market Cap:
€111.5m
Relative Value
There is not enough data to reliably calculate the relative value of HAEK.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HAEK
Relative Value
Base Case
Not Available
Multiples Across Competitors
HAEK Competitors Multiples
Haemato AG Competitors
Haemato AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Haemato AG
XETRA:HAEK
|
111.5m EUR | 0.4 | 11.6 | 8.5 | 9.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
118.8B USD | 0.3 | 27.5 | 19.4 | 21.8 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.9B USD | 0.2 | 43.6 | 15.3 | 19.3 | |
| US |
|
Cencora Inc
NYSE:COR
|
70.6B USD | 0.2 | 43.9 | 15.4 | 19.5 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
54.1B USD | 0.2 | 32.3 | 15.5 | 20.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.7B AUD | 5.8 | 65.4 | 49.4 | 49.4 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.7B USD | 0.7 | 24.5 | 11.6 | 16.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.9B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.2B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67.1B HKD | 0.1 | 8.7 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
